Spineway SA (ALSPW) AI Stock Analysis

• Market Cap: €7.10M
• Dividend Yield: N/A
• Average Volume (3M): 810.53K
• Price to Earnings (P/E): ―
• Beta (1Y): 6.65
• Revenue Growth: -5.46%
• EPS Growth: 99.75%
• Country: FR
• Employees: 48
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): -0.12
• Shares Outstanding: 35,544,390
• 10 Day Avg. Volume: 1,715,549
• 30 Day Avg. Volume: 810,526
• PEG Ratio: <0.01
• Price to Book (P/B): <0.01
• Price to Sales (P/S): 0.00485
• P/FCF Ratio: >-0.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: €0.00 ▼(-100.00% Downside)

The overall stock score of 46 reflects significant challenges in financial performance, particularly in profitability and cash flow management. While technical indicators show bullish momentum, the high RSI suggests caution. The valuation is weak due to negative earnings and no dividend yield, further impacting the score.

Spineway SA Business Overview & Revenue Model

Company Description

Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; kili, an anterior lumbar interbody fusion cage; twin peaks plif bullet shaped posterior lumbar interbody fusion cages; twin peaks olif graft vascularization interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides sonora, a biomaterial for bone regeneration. In addition, the company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.

How the Company Makes Money

Spineway generates revenue primarily through the sale of its spinal implant products and surgical instruments to hospitals and medical facilities. The company’s revenue model is based on direct sales, as well as potential partnerships with distributors and medical institutions. Key revenue streams include the sale of various spinal implants, such as intervertebral cages, screws, and rods, as well as surgical instruments used in spinal procedures. Additionally, Spineway may benefit from ongoing relationships with healthcare providers, offering training and support services that can lead to repeat business and long-term contracts.

Spineway SA Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement
Total Revenue	11.15M	10.52M	7.43M	4.29M	3.38M	5.59M
Gross Profit	6.07M	1.63M	237.00K	-1.45M	-2.12M	1.90M
EBITDA	2.24M	-4.79M	-2.76M	-719.00K	-1.32M	-1.55M
Net Income	-1.89M	-6.51M	-3.14M	-1.58M	-14.05M	-2.88M
Balance Sheet
Total Assets	30.20M	26.31M	27.70M	25.57M	14.75M	12.77M
Cash, Cash Equivalents and Short-Term Investments	4.03M	1.80M	5.50M	13.89M	4.86M	2.58M
Total Debt	1.55M	2.60M	2.92M	2.40M	2.89M	4.61M
Total Liabilities	6.34M	7.26M	5.69M	4.69M	4.73M	6.28M
Stockholders Equity	23.86M	19.05M	22.00M	20.88M	10.02M	6.49M
Cash Flow
Free Cash Flow	580.00K	-7.29M	-13.89M	-2.88M	-1.39M	-6.37M
Operating Cash Flow	580.00K	-5.83M	-1.62M	-1.79M	-408.00K	-1.16M
Investing Cash Flow	-1.41M	-1.39M	-10.20M	-578.00K	-979.00K	-5.21M
Financing Cash Flow	3.23M	3.49M	3.72M	11.45M	3.67M	8.96M

Spineway SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.18
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALSPW, the sentiment is Positive. The current price of 0.18 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.13, and above the 200-day MA of 0.12, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 74.15 is Negative, neither overbought nor oversold. The STOCH value of 75.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALSPW.

Spineway SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ALSPW	46 Neutral	€7.10M	―	-8.42%	―	-5.46%	99.75%